Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the opening of Curaleaf Bordentown, the company’s 109th dispensary nationwide. The Company also announced the launch of its Select brand in New Jersey, expanding the brand’s reach to 19 states. Select Bites, which feature the brand’s award-winning, concentrated broad-spectrum oil and science-based formulations that offer precise, consistent cannabis experiences for any occasion, are now available at all Curaleaf New Jersey locations.
Curaleaf Bordentown is a 9,546 square foot dispensary located at 191 Route 130, and is the second location that Curaleaf has opened in the state this year. All three of Curaleaf’s New Jersey dispensaries are strategically positioned near the New York and Pennsylvania borders, allowing the Company to better serve the growing East Coast adult-use market. In June, Curaleaf started serving patients at Curaleaf Edgewater Park and announced that it had tripled its cultivation capabilities with its new facility in Winslow Township. Curaleaf’s strategic expansion in New Jersey will allow the Company to serve both the existing medical market and the forthcoming adult-use market, which could launch as early as the end of this year. Through these latest expansion plans, Curaleaf expects to add over 200 new jobs to the local economy.
“It has been a privilege to serve New Jersey’s medical community over the past six years, and we look forward to forging new patient connections in Bordentown, generating new economic opportunities and delivering exceptional retail experiences as this market continues to mature,” said Patrik Jonsson, Curaleaf Regional President, Northeast. “We are also excited to expand our Select retail footprint and introduce Select Bites to new patient and consumer audiences.”
Select Classic Bites are available in three flavors including Passion Fruit, Strawberry Peach and Blueberry. Later this year, Select Nano Bites and Select Squeeze will be introduced to the New Jersey market.
Starting on August 25, Curaleaf Bordentown will offer swag bags for the first 500 patients through the door and a 20% discount on first purchases throughout the first two weeks of opening. Additionally, Curaleaf will be making a donation of $5,000 to Habitat for Humanity of Burlington & Mercer Counties and has committed to volunteering to help build homes in the area in October. For more information on Curaleaf Bordentown and its selection of branded flower, vapes and ingestible products, please visit https://curaleaf.com/locations/.
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 109 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 5,000 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
